| Case Name | Date Filed | Judge | Drug | Patent No(s). |
|---|---|---|---|---|
|
Eisai Inc. v. BannerPharmacapsInc., 11-901 (D. Del.) |
Oct. 4, 2011 |
Hon. Gregory M. Sleet |
Targretin®(bexarotine capsules) |
5,780,676 5,962,731 |
|
Pfizer Inc. v. Watson Pharma., Inc. , 11-914 (D. Del.) |
Oct. 6, 2011 |
Hon. Berle M. Schiller |
Embeda®(morphine sulfate/naltrexone hydrochloride extended-release capsules) |
7,682,633 7,682,634 7,815,934 |
|
Pfizer Inc. v. Watson Pharma., Inc. , 11-5860 (D.N.J.) |
Oct. 7, 2011 |
Hon. Claire C. Cecchi |
Embeda®(morphine sulfate/naltrexone hydrochloride extended-release capsules) |
7,682,633 7,682,634 7,815,934 |
|
Novartis Pharma. Corp. v. Alembic Pharma. Ltd. , 11-7092 (S.D.N.Y.) |
Oct. 7, 2011 |
Hon. Harold Baer |
Exelon®(rivastigmine tartrate capsules) |
5,602,176 |
|
Purdue Pharma L.P. v. Ranbaxy, Inc. , 11-7104 (S.D.N.Y.) |
Oct. 7, 2011 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride extended release tablet) |
7,674,799 7,674,800 7,683,072 |
|
Senju Pharma. Co., Ltd. v. Hi-Tech Pharmacal Co., Inc. , 11-1059 (D. Del.) |
Oct. 11, 2011 |
Hon. Sue L. Robinson |
Zymaxid®(gatifloxacin ophthalmic solution, 0.5%) |
6,333,045 5,880,283 |
|
Warner Chilcott Co., LLC v. Watson Pharma., Inc. , 11-5989 (D.N.J.) |
Oct. 12, 2011 |
Hon. Faith S. Hochberg |
Atelvia®(risedronate sodium delayed release tablets) |
7,645,459 7,645,460 |
|
Noven Pharma., Inc. v. Watson Labs., Inc. , 11-5997 (D.N.J.) |
Oct. 13, 2011 |
Hon. Dennis M. Cavanaugh |
Daytrana® (methylphenidate transdermal patch) |
6,210,705 6,348,211 |
|
Schering Corp. v. Actavis Inc. , 11-6067 (D.N.J.) |
Oct. 13, 2011 |
Hon. Jose L. Linares |
Vytorin®(ezetimibe/simvastatin tablets) |
RE42,461 5,846,966 |
|
Alcon Pharma., Ltd. v. Perrigo Co. , 11-0732 (N.D. Tex. ) |
Oct. 14, 2011 |
Hon. Terry R. Means |
Patanase®(olopatadinehydrochloride nasal spray, 0.665%) |
7,977,376 |
|
Novo Nordisk Inc. v. SandozInc., 11-6106 (D.N.J.) |
Oct. 14, 2011 |
Hon. Freda L. Wolfson |
Prandin®(repaglinide tablets) |
6,677,358 |
|
Janssen Pharma., Inc. v. Sun Pharma Global FZE , 11-6089 (D.N.J.) |
Oct. 17, 2011 |
Hon. Stanley R. Chesler |
Ortho Tri-cyclen®LO (norgestimate/ethinyl estradiol tablets) |
6,214,815 |
|
Alkermes Pharma Ireland Ltd. v. Torrent Pharma. Ltd. , 11-1009 (D. Del.) |
Oct. 21, 2011 |
Hon. Gregory M. Sleet |
Luvox CR®(fluvoxamine maleate extended-release capsules) |
7,465,462 |
|
AstraZeneca AB v. AnchenPharma., Inc., 11-6348 (D.N.J.) |
Oct. 28, 2011 |
Hon. Joel A. Pisano |
Vimovo®(naproxen and esomeprazole magnesium delayed release tablets) |
6,926,907 6,369,085 7,411,070 7,745,466 |
|
Abbott Products, Inc. v. Perrigo Co. , 11-6357 (D.N.J.) |
Oct. 31, 2011 |
Hon. Freda L. Wolfson |
AndroGel®(testosterone gel) |
6,503,894 |
|
Senju Pharma. Co., Ltd. v. Hi-Tech Pharmacal Co., Inc. , 11-1059 (D. Del.) |
Oct. 31, 2011 |
Hon. Sue L. Robinson |
Zymar®(gatifloxacin ophthalmic solution, 0.3%)) |
6,333,045 5,880,283 |
|
Cephalon, Inc. v. Breckenridge Pharma., Inc. , 11-1070 (D. Del.) |
Nov. 2, 2011 |
Hon. Gregory M. Sleet |
Nuvigil®(armodifinil tablets) |
7,132,570 |
|
Cephalon, Inc. v. Breckenridge Pharma., Inc. , 11-6455 (D.N.J.) |
Nov. 3, 2011 |
Hon. Jose L. Linares |
Nuvigil®(armodifinil tablets) |
7,132,570 |
|
Novartis Pharma. Corp. v. Actavis South Atlantic LLC , 11-1077 (D. Del.) |
Nov. 3, 2011 |
Hon. Sue L. Robinson |
Exelon®Patch (rivastigmine transdermal system or extended release film) |
5,602,176 6,316,023 6,335,031 |
|
Novartis Pharma. Corp. v. Actavis South Atlantic LLC , 11-62371 (S.D. Fla. ) |
Nov. 4, 2011 |
Hon. William P. Dimitrouleas |
Exelon®Patch (rivastigmine transdermal system or extended release film) |
5,602,176 6,316,023 6,335,031 |
|
Celgene Corp. v. Actavis South Atlantic LLC , 11-6519 (D.N.J.) |
Nov. 4, 2011 |
Hon. Susan D. Wigenton |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
5,908,850 6,355,656 6,528,530 5,837,284 6,635,284 7,431,944 |
|
Alkermes Pharma Ireland Ltd. v. Actavis, Inc., 11-1098 (D. Del.) |
Nov. 4, 2011 |
Hon. Sue L. Robinson |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
6,228,398 6,730,325 |
|
Warner Chilcott Co., LLC v. Zydus Pharma.(USA) Inc., 11-1105 (D. Del.) |
Nov. 8, 2011 |
Hon. Richard G. Andrews |
Asacol®HD (mesalamine delayed-release oral tablet) |
6,893,662 |
|
Galderma Labs. Inc. v. AmnealPharma., LLC, 11-1106 (D. Del.) |
Nov. 8, 2011 |
Hon. Leonard P. Stark |
Oracea®(doxycycline delayed-release capsules) |
7,749,532 7,232,572 7,211,267 |
|
Cephalon, Inc. v. Mylan Pharma.Inc., 11-1111 (D. Del.) |
Nov. 9, 2011 |
Hon. Sue L. Robinson |
Fentora®(fentanyl buccal tablets) |
6,200,604 6,974,590 7,862,832 7,862,833 |
|
Novartis Pharma. Corp. v. Watson Labs. Inc. , 11-1112 (D. Del.) |
Nov. 9, 2011 |
Hon. Sue L. Robinson |
Exelon®Patch (rivastigmine transdermal system or extended release film) |
5,602,176 6,316,023 6,335,031 |
|
Abbott Labs. v. SandozInc., 11-1113 (D. Del.) |
Nov. 9, 2011 |
Hon. Sue L. Robinson |
Simcor®(niacin extended release/simvastatin tablets) |
6,080,428 6,469,035 |
|
Reckitt Benckiser LLC v. Amneal Pharma. LLC , 11-6609 (D.N.J.) |
Nov. 9, 2011 |
Hon. Joel A. Pisano |
Delsym®(dextromethorphan polistirex extended release liquid suspension) |
5,980,882 |
|
Novartis Pharma.Corp. v. Watson Labs. Inc. , 11-8130 (S.D.N.Y.) |
Nov. 10, 2011 |
Hon. Harold Baer |
Exelon®Patch (rivastigmine transdermal system or extended release film) |
5,602,176 6,316,023 6,335,031 |
|
Purdue Pharma L.P. v. Amneal Pharma., L.L.C. , 11-8153 (S.D.N.Y.) |
Nov. 10, 2011 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride extended release tablet) |
7,674,799 7,674,800 7,683,072 7,776,314 |
|
Celgene Corp. v. ParPharma., Inc., 11-6640 (D.N.J.) |
Nov. 10, 2011 |
Hon. Susan D. Wigenton |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
5,908,850 6,355,656 6,528,530 5,837,284 6,635,284 7,431,944 |
|
Alkermes Pharma Ireland Ltd. v. ParPharma., Inc., 11-1119 (D. Del.) |
Nov. 11, 2011 |
Hon. Sue L. Robinson |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
6,228,398 6,730,325 |
|
Allergan, Inc. v. LupinLtd., 11-611 (E.D. Tex.) |
Nov. 11, 2011 |
Hon. Michael H. Schneider |
Lumigan®(bimatoprost ophthalmic solution 0.01%) |
7,851,504 |
|
Aventis Pharma S.A. v. Strides, Inc., 11-1121 (D. Del.) |
Nov. 14, 2011 |
Hon. Gregory M. Sleet |
Taxotere®(docetaxel injection) |
5,714,512 5,750,561 |
|
Takeda Pharma. Co. Ltd. v. HeteroDrugsLtd., 11-8302 (S.D.N.Y.) |
Nov. 16, 2011 |
Hon. Denise L. Cote |
Actos®(pioglitazone hydrochloride tablets) |
5,965,584 6,329,404 6,166,043 |
|
Cephalon, Inc. v. ImpaxLabs., Inc., 11-1152 (D. Del.) |
Nov. 18, 2011 |
Hon. Sue L. Robinson |
Fentora®(fentanyl buccaltablets) |
6,200,604 6,974,590 7,862,832 7,862,833 |
|
The Medicines Co. v. Sun Pharma Global FZE , 11-6819 (D.N.J.) |
Nov. 21, 2011 |
Hon. Peter G. Sheridan |
Angiomax®(bivalirudin intravenous injection) |
7,582,727 7,598,343 |
|
Warner Chilcott Co., LLC v. Mylan Inc. , 11-6844 (D.N.J.) |
Nov. 22, 2011 |
Hon. Joel A. Pisano |
Generess™ Fe (norethindrone and ethinyl estradiol chewable tablet) |
6,667,050 |
|
Warner Chilcott Co., LLC v. Teva Pharma. USA Inc. , 11-6936 (D.N.J.) |
Nov. 22, 2011 |
Hon. Faith S. Hochberg |
Atelvia®(risedronate sodium delayed release tablets) |
7,645,459 7,645,460 |
|
Bristol-Myers Squibb Co. v. Apotex Inc. , 11-6918 (D.N.J.) |
Nov. 23, 2011 |
Hon. Mary L. Cooper |
Sprycel®(dasatinib tablet) |
6,596,746 7,125,875 7,153,856 7,491,725 |
|
The Medicines Co. v. Sun Pharma Global FZE , 11-15175 (E.D. Mich.) |
Nov. 23, 2011 |
Hon. Bernard A. Friedman |
Angiomax®(bivalirudin intravenous injection) |
7,582,727 7,598,343 |
|
Ferring B.V. v. Watson Pharma., Inc. , 11-853 (D. Nev.) |
Nov. 25, 2011 |
Hon. Larry R. Hicks |
Lysteda®(tranexamic acid tablets) |
8,022,106 |
|
Ferring B.V. v. Apotex, Inc. , 11-854 (D. Nev.) |
Nov. 25, 2011 |
Hon. Larry R. Hicks |
Lysteda®(tranexamic acid tablets) |
8,022,106 |
|
Senju Pharma. Co., Ltd. v. ApotexInc., 11-1171 (D. Del.) |
Nov. 28, 2011 |
Hon. Sue L. Robinson |
Zymaxid®(gatifloxacin ophthalmic solution, 0.5%) |
6,333,045 |
|
Alkermes Pharma Ireland Ltd. v. Teva Pharma. USA Inc., 11-1186 (D. Del.) |
Dec. 1, 2011 |
Hon. Sue L. Robinson |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
6,228,398 6,730,325 |
|
Abbott Labs. v. Sun Pharma. Indus. Ltd. , 11-1190 (D. Del.) |
Dec. 2, 2011 |
Hon. Sue L. Robinson |
Niaspan®(niacin extended release tablet) |
6,129,930 6,406,715 6,676,967 6,746,691 6,818,229 7,011,848 |
|
Abbott Labs. v. Wockhardt, Ltd. , 11-7046 (D.N.J.) |
Dec. 2, 2011 |
Hon. Dennis M. Cavanaugh |
Tricor®(fenofibrate tablet) |
6,277,405 7,037,529 7,041,319 |
|
Alkermes Pharma Ireland Ltd. v. Wockhardt, Ltd. , 11-7047 (D.N.J.) |
Dec. 2, 2011 |
Hon. Jose L. Linares |
Tricor®(fenofibrate tablet) |
7,276,249 7,320,802 |
|
Celgene Corp. v. Teva Pharma. USA, Inc. , 11-7064 (D.N.J.) |
Dec. 2, 2011 |
Hon. Susan D. Wigenton |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
5,908,850 6,355,656 6,528,530 5,837,284 6,635,284 7,431,944 |
|
Pfizer Inc. v. AlembicLtd, 11-1213 (D. Del.) |
Dec. 7, 2011 |
Hon. Gregory M. Sleet |
Lyrica®(pregabalin capsules) |
6,197,819 |
|
Alza Corp. v. MylanPharmaInc., 11-7158 (D.N.J.) |
Dec. 8, 2011 |
Hon. Esther Salas |
Glucotrol®XL (glipizide extended release tablets) |
5,591,454 |
|
Warner Chilcott Co. LLC v. Lupin Ltd. , 11-7228 (D.N.J.) |
Dec. 12, 2011 |
Hon. Joel A. Pisano |
Generess™ Fe (norethindrone and ethinyl estradiol chewable tablet) |
6,667,050 |
|
Janssen Pharma. Inc. v. Sandoz, Inc. , 11-7247 (D.N.J.) |
Dec. 13, 2011 |
Hon. Freda L. Wolfson |
Doribax®(doripenem injection) |
5,317,016 |
|
Cephalon, Inc. v. Celgene Corp. , 11-12226 (D. Mass.) |
Dec. 14, 2011 |
Hon. George A. O’Toole, Jr. |
Abraxane®(paclitaxelinjection) |
RE40,493 |
|
Pfizer Inc. v. Sandoz Inc. , 11-1252 (D. Del.) |
Dec. 15, 2011 |
Hon. Gregory M. Sleet |
Torisel®(temsirolimus injection) |
5,362,718 |
|
Pfizer Inc. v. Intas Pharma. Ltd. , 11-1253 (D. Del.) |
Dec. 15, 2011 |
Hon. Leonard P. Stark |
Torisel®(temsirolimus injection) |
5,362,718 |
|
Shire LLC v. Mylan Pharma. Inc. , 11-0201 (N.D. W. Va. ) |
Dec. 15, 2011 |
Hon. Irene M. Keeley |
Intuniv®(guanfacine hydrochloride extended-release tablets) |
6,287,599 6,811,794 5,854,290 |
|
Roche Palo Alto LLC v. Dr.Reddy’sLabs., Ltd., 11-1264 (D. Del.) |
Dec. 20, 2011 |
Hon. Gregory M. Sleet |
Valcyte®(valganciclovir hydrochloride) |
6,083,953 |
|
Allergan, Inc. v. Akorn, Inc. , 11-1270 (D. Del.) |
Dec. 21, 2011 |
Hon. Christopher J. Burke |
Acuvail®(ketorolac tromethamine ophthalmic solution, 0.45%) |
7,842,714 |
|
MSD Consumer Products, Inc. v. Zydus Pharma. (USA) Inc., 11-7437 (D.N.J.) |
Dec. 21, 2011 |
Hon. Peter G. Sheridan |
Zegerid OTC™ (omeprazole/sodium bicarbonate capsules) |
6,699,885 6,489,346 6,645,988 7,399,772 |
|
Santarus, Inc. v. ZydusPharma.(USA) Inc., 11-7441 (D.N.J.) |
Dec. 21, 2011 |
Hon. Peter G. Sheridan |
Zegerid Rx™ (omeprazole/sodium bicarbonate capsules) |
6,699,885 6,489,346 6,645,988 7,399,772 |
|
GlaxoSmithKline Intellectual Property Management Ltd. v. Sandoz, Inc. , 11-1284 (D. Del.) |
Dec. 23, 2011 |
Hon. Richard G. Andrews |
Veramyst®(fluticasone fuorate metered nasal spray) |
6,858,596 7,101,866 7,541,350 |
|
Merck Frosst Canada & Co. v. Mylan Pharma. Inc. , 11-7569 (D.N.J.) |
Dec. 29, 2011 |
Hon. Freda L. Wolfson |
Singulair®(montelukast sodium oral granules eq. to 4 ml base/packet) |
8,007,830 |
|
Allergan, Inc. v. Lupin Ltd. , 11-0530 (E.D. Tex.) |
Dec. 30, 2011 |
Hon. David Folsom |
Acular LS®(ketorolac tromethamine ophthalmic solution, 0.4%) |
8,008,338 |
